Evidence map›Paper›PMID 36432569›Full record

ArticleNutrients2022

Neurotrophic Role of the Next-Generation Probiotic Strain

Mengyun Yue, Jing Wei, Wenjie Chen, Daojun Hong, Tingtao Chen, Xin Fang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Antioxidants (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Administration of a Next-Generation ProbioticThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Mengyun YueDepartment of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Jing WeiNational Engineering Research Center for Bioengineering Drugs and Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, China.
Wenjie ChenQueen Mary School, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.ORCID 0000-0002-0078-3805
Daojun HongDepartment of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Tingtao ChenNational Engineering Research Center for Bioengineering Drugs and Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, China.ORCID 0000-0002-0506-8536
Xin FangDepartment of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Nanchang University · CN

Funding

Double Thousand Plan of Jiangxi Province High-End Talents Project of Scientific and Technological InnovationMajor Disciplines of Academic and Technical Leaders Project of Jiangxi Province 20194BCJ22032Major Disciplines of Academic and Technical Leaders Project of Jiangxi Province 20213BCJL22049National Natural Science Foundation of China 82060222National Natural Science Foundation of China 82060638Science and Technology Plan of Jiangxi Health Planning Committee 202210390
6 · The paper itself

Abstract

Parkinson's disease (PD) is a neurodegenerative disease (NDD) with high and ongoing morbidity, bringing heavy burdens to PD patients seriously. Finding neurotrophic drugs still remains vital due to the limited drug spectrum available currently. Substantial evidence suggests that glucagon-like peptide 1 (GLP-1) exerts neuroprotection on PD, yet the short-lived biological activity markedly hindered its application. Herein, we investigated the neurotrophic role of the next-generation probiotic strain

Indexed as

FerroptosisNeurodegenerative DiseasesParkinson DiseaseProbiotics1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAnimalsDysbiosisGlucagon-Like Peptide 1Kelch-Like ECH-Associated Protein 1MiceNF-E2-Related Factor 21-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineGlucagon-Like Peptide 1Kelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2dysbiosisferroptosisglucagon-like peptide-1 (GLP-1)L. lactis MG1363-pMG36e-GLP-1oxidative stressParkinson’s disease (PD)

Identifiers

PMID36432569
PMCPMC9698534
OpenAlexW4309736718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.